George J. Netto MD
@DrNetto
Simon Flexner Professor & Chair of Path & Lab Med @PennMedicine| Views are my own not Penn’s
Coming Soon !!! PRECISION PATHOLOGY PODCAST Available on iTunes, Spotify and any of your favorite podcasts platforms. @ESP_Pathology @PennPathLabMed @PennMedicine @TheUSCAP @ASCP_Chicago @ModernPathology @Histo_Journal @AMPath @Scopus @NaturePortfolio @SpringerNature

Congratulations to our brilliant faculty @DengYanxiang and his team. Phenomenal work developing spatial technologies at @PennPathLabMed @PennMedicine @TheUSCAP @ESP_Pathology
Our spatial FFPE-ATAC-seq is now published in @NatureComms! With extensive optimizations, it performs well across diverse tissues, unlocking the vast FFPE archive for spatial epigenomics. Big congrats to Pengfei Guo @pengfeo, Yufan Chen, and the team! nature.com/articles/s4146…
Now that is COOL! @Penn @PennMedicine penntoday.upenn.edu/news/penn-de-l…
Congratulations Zhi ! @ZhiHuangPhD @PennMedicine @PennPathLabMed
#ICYMI: An AI collaboration framework, developed by @ZhiHuangPhD (@PennPathLabMed) & colleagues, was recently featured on the cover of @natBME nature.com/natbiomedeng/v…
More than 16 million Americans are at risk of losing their health care because Republicans in Congress are rushing to pass a bill that would cut federal funding for Medicaid and weaken the Affordable Care Act. If the House passes this bill, it will increase costs and hurt…
A big thank you to @KMirza Dr. Kamran Mirza for delivering a great final Grand Rounds of the season earlier today. His talk was an informative discussion on the possibilities of increased personalization in pathology education. #pathology
Such a pleasure to host you Dr. @KMirza in our department! Thank you for an inspiring lecture and visit to @PennPathLabMed
Had an incredible time visiting Philadelphia and hanging out at @PennPathLabMed medicine talking about the past, present, and future of #pathology education and how to find personalized pedagogy solutions both for our global and our local learners! It was an honor to visit! cc:…
Had an incredible time visiting Philadelphia and hanging out at @PennPathLabMed medicine talking about the past, present, and future of #pathology education and how to find personalized pedagogy solutions both for our global and our local learners! It was an honor to visit! cc:…
A big thank you to @KMirza Dr. Kamran Mirza for delivering a great final Grand Rounds of the season earlier today. His talk was an informative discussion on the possibilities of increased personalization in pathology education. #pathology
👏👏👏Fluminense 2-0 Inter Milan (Jun 30, 2025) Final Score - ESPN - via @ESPN App espn.com/soccer/match/_…
Congratulations to our faculty Dan Powell and team for successfully targeting Mutant KRAS peptide with CAR-T cells. @TheUSCAP @ASCP_Chicago KRAS peptide targeted CAR-T cells engineered for cancer therapy: Cancer Cell cell.com/cancer-cell/fu…
Big News for CAR T cell delivery to patients and monitoring: FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies #FDA #Tcellrx #immunotherapy fda.gov/vaccines-blood…
See you in Vienna @ESP_Pathology @PennPathLabMed @PennMedicine @pathologistmag @ASCP_Chicago
🎉Meet the #ESPCongress Keynote Speakers, part 4! 👨🏫George Netto (@DrNetto) is a #pathology Professor at the University of Pennsylvania, US! ✍️Talk title: "Precision Pathology: The Future is Now" 📅10 September ℹ️More info: espcongress.org/keynote-speake… #PathTwitter #pathX
#PathTwitter R U ready for this❓ 🎉Applications for the ESP Giordano Fellowship 2026 edition are now open! GF is a post-graduate #pathology training programme, at one of the ESP Advanced Training Centres! Selection of Fellows is highly competitive! ℹ️esp-pathology.org/giordano-fello…
See you all @ESP_Pathology 2025 in Vienna! Great Line Up 😀

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception: Cancer Cell cell.com/cancer-cell/fu…
Proud of our young investigators! Congratulations @NourShobaki @PennPathLabMed
Thanks Prostate Cancer Foundation @PCFnews for supporting young investigators! pcf.org/our-work/the-w…
The story keeps getting better for our @PennPathLabMed faculty @LambrisJD discoveries in C3 therapeutics. John’s contributions to Ocular Geographic Atropy therapy continue to benefit hundreds of thousands of patients around the globe. @TheUSCAP @ESP_Pathology @PennMedicine
Syfovre, the PEGylated version of a 2nd-generation compstatin-based C3 therapeutic (Cp05) discovered in my lab at the University of Pennsylvania (pubmed.ncbi.nlm.nih.gov/16854067/) shows a consistent safety profile over 36 months of treatment, with increasing efficacy in reducing GA lesion…
Building upon prior success in a small group of CRCa patients, Luis Diaz group from MSKCC achieved remarkable response with ICI treatment alone in a large cohort of patients with d-MMR tumors from GI,GU,GYN sites avoiding surgery! @AACR @NEJM nejm.org/doi/full/10.10…